9th CRYSTAL FORMS@BO CONVENTION

9th CRYSTAL FORMS@BO CONVENTION (4-6th June 2017, Bologna)  “CRYSTALLIZATION BY DESIGN” Making, discovering, protecting and using crystal forms About the Convention The invest

Read all

Highly Potent API

Polycrystalline is expanding its HPAPI offerings, up to OEB 5 level of containment for the synthesis, study and development of anti-cancer and cytotoxic APIs. Polycrystalline has invested in capacity

Read all

Crystallisation by Design

The development of new pharmaceutical products is often hindered by difficulties in obtaining the drug as a stable crystalline solid. Since 2005 the mission of PolyCrystalLine is to support our client

Read all

High Technology Network

Polycrystalline is part of the High Technology Network of Emilia-Romagna, in the platform of Life Sciences. The High Technology Network of Emilia-Romagna, consisting of industrial research labs and in

Read all

“... every compound has
different polymorphic forms...
and the number of forms known for a given
compound is proportional to the time and
money spent in research on that compound.”

McCrone, 1965‏

© Copyright Polycrystalline SpA - All rights reserved - VAT IT02600021204 / powered by DibiWeb